- Industry
- 2 min read
Fullife Healthcare receives US$22 mn funding from Morgan Stanley Private Equity Asia
The investment will be instrumental in accelerating the growth of flagship brands Fast & Up and Chicnutrix
Fullife Healthcare is one of the first Indian companies to take branded business outside India in the field of wellness and active nutrition. The company is dedicated towards manufacturing high-quality promising products that deliver performance, catering to the needs of its consumers.
Commenting on the capital raise, Varun Khanna, CEO of Fullife Healthcare said, “It is amazing to have Morgan Stanley as a part of the narrative we are building at Fullife and our brands Fast&Up and Chicnutrix. Our focus has always been to bring forth high-quality nutrition to India, making sure that Indians get the best-in-class supplements to keep them active and feeling good. Indians are now more aware and actively searching for products that are genuine, high quality and align with the daily needs to be healthy, active and look good. We are building these brands at an international level even in several regulated markets as a first for Indian OTC brands. With our brands being available in multiple countries, we are excited about the story we are building and are grateful for the trust that MSPEA has put in us.”
This round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally. Both of these home-grown brands have been aggressively entering into new categories and leading the pack when it comes to providing nutrition solutions for a healthy and active lifestyle.
Nirav Mehta, Managing Director, MSPEA said, “MSPEA is very excited to invest into Fullife, which is carving a niche in the new-age nutrition, active lifestyle and wellness space through its novel effervescent and plant-based offerings. Fullife’s key brands Fast&Up and Chicnutrix are already household names, and the company is well positioned to emerge as a leading global player in the space, backed by its wide product portfolio, in-house manufacturing capabilities, global business footprint and omni-channel distribution.”
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions